Besifloxacin Nanocrystal: Towards an Innovative Ophthalmic Preparation
Bacterial conjunctivitis significantly impacts public health, including more than one-third of eye diseases reported worldwide. It is an infection caused by various aerobic and anaerobic bacteria and is highly contagious. Therefore, it has a high incidence of bacterial resistance to the antibiotics...
Main Authors: | José Izo Santana da Silva de Jesus, Felipe Rebello Lourenço, Kelly Ishida, Thayná Lopes Barreto, Valdir Carlos Avino, Edson dos Santos Neto, Nádia Araci Bou-Chacra |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/10/2221 |
Similar Items
-
Characterization of Polybacterial versus Monobacterial Conjunctivitis Infections in Pediatric Subjects Across Multiple Studies and Microbiological Outcomes with Besifloxacin Ophthalmic Suspension 0.6%
by: Blondeau JM, et al.
Published: (2021-11-01) -
Treating with besifloxacin for acute bacterial conjunctivitis: a Meta-analysis
by: Jun-Jie Wang, et al.
Published: (2019-12-01) -
Nano-Formulating Besifloxacin and Employing Quercetin as a Synergizer to Enhance the Potency of Besifloxacin against Pathogenic Bacterial Strains: A Nano-Synergistic Approach
by: Turki Al Hagbani, et al.
Published: (2023-07-01) -
Spectral Analysis and Structural Elucidation of Besifloxacin Hydrochloride
by: ZHANG Ming-guang, et al.
Published: (2018-09-01) -
In Vitro Time-Kill of Common Ocular Pathogens with Besifloxacin Alone and in Combination with Benzalkonium Chloride
by: Joseph Blondeau, et al.
Published: (2021-05-01)